Streptococcal lung abscesses from a dental focus following tocilizumab: a case report

MD de Kruif, Eric van Gorp, EH Bel, DM Gerlag, PW Kunst

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)


Patients suffering from dental infections and concurrently using immunosuppressive medication are at increased risk of developing systemic streptococcal infections. Tocilizumab is a novel therapeutic agent targeting interleukin-6. We describe a case of streptococcal lung abscesses from a dental focus after use of tocilizumab for treatment of Takayasu arteritis.
Original languageUndefined/Unknown
Pages (from-to)951-953
Number of pages3
JournalClinical & Experimental Rheumatology
Issue number6
Publication statusPublished - 2012

Cite this